Skip to main content

Smoking Cessation Programs for E-cigarette Users

Date:
April 24, 2020

Your BlueCross BlueShield patients have smoking cessation coverage that applies to the use of e-cigarettes, or “vaping”. It’s important for your patients to know that e-cigarettes and vapes are NOT approved tobacco cessation tools and contain nicotine and other potentially harmful substances. Patients using these electronic nicotine delivery system (ENDS) products should have a quit plan in place. There are many resources and programs available for those struggling to quit, at low or no cost.

Screening, Brief Intervention and Referral to Treatment (SBIRT) should be used to screen patients for nicotine use. The American Academy of Pediatrics (AAP) also provides a useful handout with guidance for how to talk about e-cigarette use with patients and families. Patients who would like to quit any tobacco product (including ENDS devices) can be referred to our smoking cessation program. A prescription is all that is needed for coverage of tobacco treatment medications.

Resources are limited for teens and adolescents who are trying to stop their use of vaping or other tobacco products. We recently awarded a Blue Fund grant to Kids Escaping Drugs for the expansion of a vaping intervention program, which aims to educate area middle and high school students, as well as parents, on vaping.

We have partnered with Roswell Park Cancer Institute to offer access to their quit coaches, who are qualified in any type of nicotine addiction treatment. Patients can be registered by visiting Roswell Park Cessation Services online, or by calling 1-877-500-2393. Your patients also have access to support from our health coaches, who are available to help with this, or any other type of behavior change goal. You (or they) can call 1-877-878-8785, option 2.

Many BlueCross BlueShield patients are covered with a $0 cost-share for these services.

If your patients insist on using vaping products, encourage them not to buy unregulated or black market vaping products of any kind.

Recent Articles

  • Individual Provider Recontracting Initiative
    We will be amending and restating our existing contracts. Starting next month, all directly contracted individual providers will be sent an updated contract. The New York State Department of Health (DOH) requires that each provider sign and return their amended/restated contract.
  • New Digital Provider and Facility Reference Manual
    We’ve upgraded our Provider and Facility Reference Manual, which is now available in digital format. The new manual offers a better, more interactive user experience. Here, we highlight some of the new features.
  • Updates to Screening for Hepatitis C Virus (HCV) in Adults
    Hepatitis C virus (HCV) is reportedly the most common blood infection in the country. The U.S. Preventive Services Task Force has updated the recommendation for HCV screening in March 2020 to now include all adults ages 18 to 79 without known liver disease, regardless of their risk for infection.
  • Update to Spine Preauthorization Process
    To help streamline the preauthorization process for spine procedures and injections, all these requests will be submitted directly to our Utilization Management Department beginning October 1, 2020. We will no longer require any requests to be submitted through Palladian Health.
  • Care at Home Expanded for Medicare Advantage Patients
    Beginning on July 7, more Medicare Advantage patients will be eligible to enroll in a new extension of the Care at Home program -- Care at Home℠ On Call -- which offers some urgent care in-home services. Care at Home On Call will be offered to newly enrolled Medicare Advantage members.

Working with Us

Additional Resources

We want to hear from you! Have a topic request for the next Blue Bulletin? Email us

Stay in Touch! Sign up to receive emails for provider news and information